Economic Research: U.S. Weekly Financial Notes: Not So Fast Dec 11

  • ID: 2033718
  • December 2011
  • Region: United States
  • Standard & Poors
1 of 2

The Fed couldn't quite take the protective gear off the U.S. economy this week. The Federal Reserve's Federal Open Market Committee (FOMC) upgraded the U.S. economic outlook in its policy statement. While it noted "significant downside risks to the economic outlook," largely from turmoil in Europe, it wasn't ready to launch another round of quantitative easing just yet, much to markets' dismay. Other economic releases this week include: U.S. November retail sales rose just 0.2% over October, while auto sales were up 0.5%. Excluding auto sales, retail sales also rose just 0.2% over October. The U.S. government budget deficit fell 9% in November to $137.30 billion from the previous year's $150.39 billion. In fiscal 2011, ended September 30, the deficit...

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Commentary
Criteria articles describe the thought process and methodology Standard & Poor's analysts use in determining ratings. These commentary pieces discuss both the quantitative (economic and financial) and qualitative (business analysis and caliber of management) aspects of the analysis, as well as legal issues.

Note: Product cover images may vary from those shown
2 of 2
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.